<DOC>
	<DOC>NCT02422277</DOC>
	<brief_summary>The aim of this clinical trial is to evaluate the role of extracorporeal low-intensity shock wave therapy in penile rehabilitation post nerve sparing radical cysto-prostatectomy.</brief_summary>
	<brief_title>Role of Low-intensity Shock Wave Therapy in Penile Rehabilitation Post Nerve Sparing Radical Cysto-prostatectomy</brief_title>
	<detailed_description>60 patients for whom nerve sparing radical cystoprostatectomy will be carrried out, penile rehabilitation by using low intensity extracorporeal shock wave therapy will be applied in 20 patients, another 20 patients will receive oral phosphodiestrase type 5 inhibitorrs and 20 patients will not receive any interventions in the control group.</detailed_description>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Phosphodiesterase 5 Inhibitors</mesh_term>
	<criteria>Patients will be eligible if he is sexually motivated and potent men with stable relationship of more than 6 months duration who will undergo nerve sparing radical cystoprostatectomy for organconfined bladder cancer. 1. Men with Peyronie's disease. 2. Inflammation in the shock wave area. 3. Evidence of disease failure after surgery. 4. Patients developing postoperative complications requiring hospital readmission after surgery which interferes with the process of SWL. 5. Unstable medical or psychiatric disorder.</criteria>
	<gender>Male</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Cystoprostatectomy</keyword>
	<keyword>Sexual function</keyword>
	<keyword>Phosphodiestrase 5 inhibitors</keyword>
	<keyword>Low intensity extracorporeal shock wave therapy</keyword>
	<keyword>Erectile dysfunction</keyword>
	<keyword>Penile rehabilitation</keyword>
</DOC>